期刊文献+

肿瘤坏死因子-α及其基因863C—A多态性与壮族甲状腺相关眼病的相关性研究

Correlation research between Gene Polymorphism of TNF-alpha Gene 863C_A and Thyroid Associated Ophtalmopathy in Zhuang Ethnic Population
原文传递
导出
摘要 目的 探讨肿瘤坏死因子-α(TNF-α)及其基因863C_A多态性与壮族甲状腺相关眼病(TAO)的相关性。方法 选择壮族TAO患者与汉族TAO患者作为研究对象,并分别选择健康壮族人与汉族人设立对照。抽取患者血液制备血清及DNA样本,分别采用酶联免疫吸附法测定血清TNF-α水平,采用聚合酶链反应(PCR)法检测TNF-α 863C_A位点基因多态性。结果 与对照组比较,TAO患者血清TNF-α水平显著升高(P〈0.05),壮族TAO患者升高更为显著(P〈0.05);壮族人群TAO患者CA基因型频率(36.9%)显著高于汉族人群TAO患者(22.3%),AA基因型频率(19.6%)显著低于汉族人群TAO患者(21.3%)(χ2=0.770、2.145,均P〈0.05)。结论 TAO发病时血清TNF-α水平显著升高,在汉族与壮族之间存在差异,可能由于基因多态性引起。 Objective To explore correlation between gene polymorphism of TNF-alpha and thyroid associated ophtalmopa thy (TAO) in Zhuang ethnic population.Methods DNA and serum samples were collected in patients with TAO in Han/Zhuang population.ELISA was applied to detect level of TNF-alpha in serum and PCR was applied to detect polymorphism of TNF-alpha gene 863C_A.Results The levels of TNF-alpha in patients with TAO increased significantly compared with control group(P〈0.05),and more significantly in Zhuang population compared with Han population(P〈0.05);gene frequency of CA was significantly higher in patients with TAO in Zhuang population than that in Han population(P〈0.05),while gene frequency of AA was significantly lower(χ2=0.770,2.145,all P〈0.05). Conclusion Serum level of TNF-alpha increases during occurrence of TAO,and the differences of expression level between different nationalities are due to gene polymorphism of TNF-alpha.
作者 马文豪 覃瑞
出处 《中国基层医药》 CAS 2013年第1期18-20,共3页 Chinese Journal of Primary Medicine and Pharmacy
基金 广西壮族自治区教育厅科研项目(桂教科研[2006]26号)
关键词 肿瘤坏死因子 基因多态性 格雷夫斯病 Tumor necrosis factor Gene polymorphism Graves,disease
  • 相关文献

参考文献9

二级参考文献53

  • 1鲁扬,黄勇敏.甲泼尼龙不同用药方案治疗甲状腺相关眼病的对照研究[J].中国全科医学,2009,12(11):1012-1013. 被引量:1
  • 2郑建国,张霞,龚日祥,王继,谭天秩.Graves眼病的治疗[J].生物医学工程学杂志,2004,21(5):876-878. 被引量:5
  • 3董吉祥,陈永珍,刘志达,顾宗江,韩惠琴,郑列琳,张学光.慢性肾炎患者白细胞介素-6及T细胞亚群变化的探讨[J].标记免疫分析与临床,1994,1(2):76-78. 被引量:9
  • 4李卫红,吕建新,张建国,刘书院.抗甲状腺药物治疗Graves病的疗效与疗程观察[J].中国医药导报,2007,4(06X):64-65. 被引量:6
  • 5廖二元.甲状腺功能亢进症[A].叶任高主编.内科学:第5版[C].北京:人民卫生出版社,2001.738.
  • 6Weetman AP, Hunt PJ. The immunogenetics of thyroid-associated orbitopathy. Exp Clin Endocrinol Diab,1999,107:S149-S151.
  • 7Allahabadia A,Heward JM,Nithiyananthan R,et al. MHC class Ⅱ region, CTLA-4 gene ,and ophthalmopathy in patients with Graves' disease. Lancet, 2001, 358:984-985.
  • 8Larsen PR, Davis TF, Hay ID. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, et al, eds. Williams Textbook of Endocrionology . 9th ed. Philadephia: WB Sauners, 1998. 389-516.
  • 9Mantel N,Hanzszel W. Statistical aspects of the analysis of data from retro- spective studies of disease. J Nat Can Inst, 1959,22:719-748.
  • 10Bartalena L,Pinchera A,Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev,2000,21:168-199.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部